Sponsored by

Chimerix

Please click on the above banner for more details

WEBSITECHANGES

You can Subscribe to our RSS FEED: which delivers brain tumor news and additions to the website via RSS.

Click HERE for details on RSS.

Displaying items 726 to 750 of about 5882

Previous 25

Website Changes

03/02/2021

The UCLA Brain Tumor Center will host part two of its Brain Tumor Virtual Conference on Friday, March 12th

02/28/2021

02/21/2021

The addition of chloroquine and bevacizumab to standard radiochemotherapy for recurrent glioblastoma multiforme

02/20/2021

Phase I trial of intranasal NEO100, highly purified perillyl alcohol, in adult patients with recurrent glioblastoma

02/19/2021

Setting international standards in analyzing patient-reported outcomes and QOL endpoints

02/16/2021

Are you Considering Optune Therapy for GBM?

02/16/2021

New zebrafish model could help advance glioblastoma multiforme research

02/16/2021

Brain tumor study reveals surprising gene deletion and method to overcome drug resistance

02/15/2021

The effects of releasing early results from ongoing clinical trials

02/12/2021

Sydney researchers identify/advance potential revolutionary new drug treatment for fatal childhood cancer

02/09/2021

New combination treatment approach improves overall survival in mice with glioblastoma

02/06/2021

Amazon Smile Fundraiser! Action Required!

02/06/2021

GammaTile webinar posted to our video library!

02/04/2021

Musella Foundation awards two brain tumor research grants!

02/02/2021

First Glioblastoma Patient Dosed in Phase 2 Trial Testing PVSRIPO Plus Keytruda

02/01/2021

Very Low Mutation Burden Is a Feature of Inflamed Recurrent Glioblastomas Responsive to Cancer Immunotherapy

01/29/2021

Mebendazole and temozolomide in patients with newly diagnosed high-grade gliomas: results of a phase 1 clinical trial

01/27/2021

Imvax Announces Publication of Phase 1b Clinical Trial of IGV-001 for Patients with Newly Diagnosed Glioblastoma in Clinical Cancer Research

01/27/2021

Learn More About GammaTile® Therapy, Surgically Targeted Radiation Therapy For Brain Tumors, At Patient Education Event On Thursday, February 4

01/26/2021

NEW MAGNETIC RESONANCE IMAGING (MRI) TECHNIQUE UNCOVERS PATHOPHYSIOLOGICAL PROCESS TO HELP EARLY DETECTION OF RECURRENT GLIOBLASTOMA

01/23/2021

Targepeutics Receives Orphan Drug Designation for Lead Drug Targeting Malignant Glioma

01/23/2021

Outcomes and Patterns of Care in Elderly Glioblastoma Multiforme Patients: A Population-Based Study of the National Cancer Database

01/22/2021

The Role of Temozolomide in Patients With Newly Diagnosed Wild-Type IDH, Unmethylated MGMTp Glioblastoma During the COVID-19 Pandemic

01/21/2021

Brain Cancer Advocate Al Musella Joins Childhood Cancer Foundation Board of Directors

01/16/2021

Body mass index as an independent prognostic factor in glioblastoma

Our privacy / cookie policy has changed.
Click HERE to read it!